Twist Bioscience(TWST) - 2025 Q1 - Quarterly Results

— Expect revenue in the range of $372 million to$379 million for full year fiscal 2025; expect gross margin over 50% for 4QFY25 — SOUTH SAN FRANCISCO, Calif. -- (February 3, 2025) — Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today reported financial results and business highlights for the first quarter of fiscal 2025 ended December 31, 2024. "We ended the first quarter of fiscal 2025 with our eighth con ...